Please login to the form below

Not currently logged in
Email:
Password:

UK lags behind other countries in use of branded drugs

UK flag

ABPI claims use of innovative new treatments is lower than international average in seven out of 11 classes

Boehringer’s Vargatef approved in the EU for lung cancer

EU flagMarks company’s second oncology drug to hit market

Novartis' heart failure drug on EMA's fast track

Novartis buildingCandidate is the first cardiovascular drug to get accelerated review in the EU

NICE overturns negative Glivec guidance

Novartis Glivec imatinib leukaemiaRecommends drug for reimbursement in GIST four years after rejection

NICE set to back Alexion's costly 'ultra-orphan' drug

Final draft guidance recommends aHUS treatment Soliris

New European health comms network launches

packer forbes alexa forbesFounding members of HEAL include the UK’s Packer Forbes and CGC of Germany

First trial results positive for GSK Ebola vaccine

GSK GlaxoSmithKline houseChAd3-EBO is safe and able to stimulate response

BMS' daclatasvir scuppered by decision to drop companion drug

BMS Daklinza daclatasvir hepatitis CFDA denies approval due to discontinuation of asunaprevir development

NICE backs drug to cut alcohol consumption

Lundbeck selincro nalmefeneFinal guidance for Lundbeck’s Selincro for use on NHS in England

FDA headquarters White OakThe biosimilars are coming

Lilly on navigating the regulatory pathway for its insulin glargine

Latest appointments

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

More of the same: The importance of strategic communications planning for biosimilar entry
GCI Health's Hannah Morris considers the importance of strategic communications planning for biosimilar entry, a market anticipated to deliver between €8-26bn in savings across the European Union by 2020....
Online Physician Communities
How can pharma realise the power of digital?
Firstly, by making it owned and driven by the most senior leadership team in the business...
Remapping the market: Does Pharma's global model need a shake up?
For patients, carers and professionals, wherever they are in the world, digital technology is inherent in their everyday lives. Digital is, so to speak, a global language. The success of...